Launch and sales expansion of the laser eyewear business

「The Visual Information Devices (VID) Business Division was renamed the Laser and Optical Solutions (LS) Business Division.」

「We began test marketing RETISSA VIEWCLEAR, a new non-eyeglass-type consumer product, in May 2026.」

「During the six-month period, sales of retinal-projection products declined 98.5% from the same period of the previous year, mainly because no sales were recorded for the self-check service as a result of the previously described voluntary product recall. Meanwhile, orders for development contracts centered on various elemental technologies, including an eye-tracking drive system for next-generation retinal-projection eyewear (smart glasses), increased, and development-contract sales rose 385.9% year on year.」

「From the fiscal year, the reporting segment formerly called the laser eyewear business was renamed the visual information device business. This was only a change in the reporting segment name and had no impact on segment information.」

「As a result, sales for the six-month period were ¥559,360 thousand, down 12.4% year on year. Selling, general and administrative expenses continued to exceed gross profit as sales channels were still being developed following a change in the sales policy for the visual information device business. Operating loss was ¥295,468 thousand, compared with an operating loss of ¥243,330 thousand in the same period of the previous year; ordinary loss was ¥302,820 thousand, compared with ordinary loss of ¥248,611 thousand; and interim net loss was ¥303,927 thousand, compared with interim net loss of ¥250,801 thousand.」

「In the fiscal year, sales increased from the previous fiscal year because of North American sales of RETISSA NEOVIEWER, a retinal-projection viewfinder, and higher sales of RETISSA MEOCHECK, an eye-health check tool, and eye-health check services. Sales of RETISSA ON HAND, a retinal-projection electronic magnifier, declined from the previous fiscal year because of a market review, but overall sales increased.」

「During the nine months ended December 31, sales increased from the previous year because of North American sales of RETISSA NEOVIEWER, a retinal-projection viewfinder, and higher sales of RETISSA MEOCHECK, an eye-health check tool, and eye-health check services. As a result, nine-month sales were ¥235,220 thousand, up 211.0% year on year, and the segment loss was ¥217,182 thousand, compared with a segment loss of ¥268,447 thousand in the same period of the previous year.」

「In the laser eyewear business, sales increased from the previous year because RETISSA NEOVIEWER, a retinal-projection viewfinder, began sales in North America, while sales of RETISSA MEOCHECK, an eye-health check tool, and eye-health check services increased. As a result, sales for the six-month period were ¥638,195 thousand, up 33.7% year on year.」

「Sales increased following the launch of sales in North America of the retinal-projection viewfinder RETISSA NEOVIEWER. As a result, first-quarter sales were ¥45,972 thousand, up 161.1% year on year, and the segment loss was ¥67,795 thousand, compared with a segment loss of ¥81,457 thousand in the same period of the previous year.」

「In fiscal 2022, we began selling 3 non-eyeglass-type new products using laser retinal-scanning technology.」

「In the laser eyewear business, sales increased from the previous year because of higher development-contract orders and the launch of optometry services.」

「During the six months ended September 30, sales increased from the previous year because we newly received development-contract orders, despite the absence of the large sales to financial-institution branches recorded in the previous year. As a result, sales for the six-month period were ¥38,306 thousand, up 13.4% year on year.」

「In the laser eyewear business, sales increased from the previous year because we newly received development-contract orders, despite the absence of the large sales to financial-institution branches recorded in the previous year.」

「In fiscal 2022, we began selling 3 new products using laser retinal-scanning technology to meet a range of market requirements.」

「During the nine months ended December 31, orders for consumer retinal-scanning laser eyewear increased through sales to financial-institution branches and the launch of sales of an accessory camera. As a result, sales for the nine-month period were ¥38,579 thousand, up 14.4% year on year.」

「During the six months ended September 30, orders for consumer retinal-scanning laser eyewear increased through sales to financial-institution branches and the launch of sales of an accessory camera.」

「In the laser eyewear business, orders for consumer retinal-scanning laser eyewear increased through sales to financial-institution branches and other channels.」

「Although the first half was affected by international travel restrictions and the closure of eyeglass stores and other businesses related to COVID-19 measures, orders increased in the second half, and we achieved our target of selling 250 units.」

「Fixed-cost expenses remained high, primarily because of development costs, as the laser eyewear business was still in the process of being launched.」